Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Berg

Showing results (361-370 of 547) with videos related to

Pageof 55
Sort By:
Frontiers in Neurology|July 6, 2019
Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's DiseaseEva Schaeffer, Jan-Hinrich Busch, Benjamin Roeben, et al.
Plos One|August 23, 2012
Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomasJulia Slotta-Huspenina, Daniela Berg, Karina Bauer, et al.
IBRO Neuroscience Reports|November 24, 2025
Evaluation of an antibody panel for alpha-synuclein detection in FFPE rectal biopsies in Parkinson's diseaseKatja Schröder, Carmen Kintrup, Kristína Kulcsárová, et al.
Molecular Genetics and Metabolism|March 27, 2024
Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patientsFriedrich Trefz, Georg Frauendienst-Egger, Gerald Dienel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 2, 2022
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson's diseaseEva Gschmack, Camelia-Maria Monoranu, Hecham Marouf, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
Vascular Risk Factors and Cognition in Parkinson's DiseaseAndrea Pilotto, Rosanna Turrone, Inga Liepelt-Scarfone, et al.
European Journal of Neurology|January 15, 2021
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseMilan Zimmermann, Leonie Köhler, Marketa Kovarova, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 30, 2014
Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controlsMaartje Louter, Walter Maetzler, Jos Prinzen, et al.
Parkinsonism & Related Disorders|December 2, 2008
Genetic factors influencing age at onset in LRRK2-linked Parkinson diseaseYulia Golub, Daniela Berg, Donald B Calne, et al.
Histopathology|March 8, 2012
Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissuesClaudia Schuster, Katharina Malinowsky, Sibylle Liebmann, et al.
Pageof 55

Showing results (361-370 of 547) with videos related to

Sort By:
Pageof 55
Frontiers in Neurology|July 6, 2019
Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's DiseaseEva Schaeffer, Jan-Hinrich Busch, Benjamin Roeben, et al.
Plos One|August 23, 2012
Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomasJulia Slotta-Huspenina, Daniela Berg, Karina Bauer, et al.
IBRO Neuroscience Reports|November 24, 2025
Evaluation of an antibody panel for alpha-synuclein detection in FFPE rectal biopsies in Parkinson's diseaseKatja Schröder, Carmen Kintrup, Kristína Kulcsárová, et al.
Molecular Genetics and Metabolism|March 27, 2024
Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patientsFriedrich Trefz, Georg Frauendienst-Egger, Gerald Dienel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 2, 2022
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson's diseaseEva Gschmack, Camelia-Maria Monoranu, Hecham Marouf, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
Vascular Risk Factors and Cognition in Parkinson's DiseaseAndrea Pilotto, Rosanna Turrone, Inga Liepelt-Scarfone, et al.
European Journal of Neurology|January 15, 2021
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseMilan Zimmermann, Leonie Köhler, Marketa Kovarova, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 30, 2014
Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controlsMaartje Louter, Walter Maetzler, Jos Prinzen, et al.
Parkinsonism & Related Disorders|December 2, 2008
Genetic factors influencing age at onset in LRRK2-linked Parkinson diseaseYulia Golub, Daniela Berg, Donald B Calne, et al.
Histopathology|March 8, 2012
Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissuesClaudia Schuster, Katharina Malinowsky, Sibylle Liebmann, et al.
Pageof 55